BETASERON: 591 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
591
Total FAERS Reports
21 (3.6%)
Deaths Reported
65
Hospitalizations
591
As Primary/Secondary Suspect
3
Disabilities
First Report: 1993 · Latest Report: 20140619
What Are the Most Common BETASERON Side Effects?
#1 Most Reported
Influenza like illness
65 reports (11.0%)
#2 Most Reported
Injection site pain
43 reports (7.3%)
#3 Most Reported
Multiple sclerosis relapse
41 reports (6.9%)
All BETASERON Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Influenza like illness | 65 | 11.0% | 0 | 2 |
| Injection site pain | 43 | 7.3% | 0 | 3 |
| Drug ineffective | 41 | 6.9% | 0 | 0 |
| Multiple sclerosis relapse | 41 | 6.9% | 1 | 8 |
| Multiple sclerosis | 38 | 6.4% | 1 | 5 |
| Injection site erythema | 35 | 5.9% | 0 | 1 |
| Depression | 33 | 5.6% | 0 | 2 |
| Fatigue | 29 | 4.9% | 0 | 2 |
| Drug dose omission | 22 | 3.7% | 0 | 5 |
| Injection site bruising | 22 | 3.7% | 0 | 2 |
| Injection site mass | 22 | 3.7% | 0 | 1 |
| Injection site reaction | 22 | 3.7% | 0 | 0 |
| Hypoaesthesia | 21 | 3.6% | 0 | 4 |
| Gait disturbance | 20 | 3.4% | 0 | 0 |
| Chills | 19 | 3.2% | 0 | 1 |
| Headache | 19 | 3.2% | 0 | 1 |
| Pain | 19 | 3.2% | 0 | 2 |
| Pain in extremity | 19 | 3.2% | 0 | 4 |
| Death | 17 | 2.9% | 17 | 3 |
| Nausea | 17 | 2.9% | 0 | 1 |
Who Reports BETASERON Side Effects? Age & Gender Data
Average age: 50.3 years. Most reports from: US. View detailed demographics →
Is BETASERON Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 3 | 0 | 0 |
| 2001 | 3 | 0 | 0 |
| 2002 | 2 | 0 | 0 |
| 2003 | 3 | 0 | 3 |
| 2004 | 8 | 0 | 2 |
| 2006 | 2 | 0 | 2 |
| 2007 | 3 | 0 | 0 |
| 2008 | 2 | 0 | 1 |
| 2009 | 3 | 0 | 1 |
| 2010 | 9 | 0 | 1 |
| 2011 | 15 | 0 | 1 |
| 2012 | 19 | 0 | 5 |
| 2013 | 78 | 6 | 13 |
| 2014 | 155 | 8 | 28 |
What Is BETASERON Used For?
| Indication | Reports |
|---|---|
| Multiple sclerosis | 367 |
| Relapsing-remitting multiple sclerosis | 71 |
| Product used for unknown indication | 19 |
| Secondary progressive multiple sclerosis | 7 |
BETASERON vs Alternatives: Which Is Safer?
BETASERON vs BETAXOLOL
BETASERON vs BETHANECHOL
BETASERON vs BEVACIZUMAB
BETASERON vs BEVACIZUMAB-AWWB
BETASERON vs BEVACIZUMAB-BVZR
BETASERON vs BEVACIZUMAB-MALY
BETASERON vs BEXAROTENE
BETASERON vs BEZAFIBRATE
BETASERON vs BEZLOTOXUMAB
BETASERON vs BGB-11417
Official FDA Label for BETASERON
Official prescribing information from the FDA-approved drug label.